The trajectory of Sildenafil presents a complex picture for those considering investment. While the initial launch generated significant profits, the lapse of its exclusive rights opened the avenue to off-brand https://hamzahjqum288468.yomoblog.com/49174459/the-copyright-and-big-pharma-a-risky-opportunity